These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18190269)

  • 1. Anti-tumor necrosis factor-alpha activation of Borrelia burgdorferi spirochetes in antibiotic-treated murine Lyme borreliosis: an unproven conclusion.
    Wormser GP; Barthold SW; Shapiro ED; Dattwyler RJ; Bakken JS; Steere AC; Bockenstedt LK; Radolf JD
    J Infect Dis; 2007 Dec; 196(12):1865-6; author reply 1866-7. PubMed ID: 18190269
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-tumor necrosis factor-alpha treatment activates Borrelia burgdorferi spirochetes 4 weeks after ceftriaxone treatment in C3H/He mice.
    Yrjänäinen H; Hytönen J; Song XY; Oksi J; Hartiala K; Viljanen MK
    J Infect Dis; 2007 May; 195(10):1489-96. PubMed ID: 17436229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor necrosis factor-alpha treatment for Lyme borreliosis.
    McSweegan E
    J Infect Dis; 2007 Dec; 196(12):1866; author reply 1866-7. PubMed ID: 18190271
    [No Abstract]   [Full Text] [Related]  

  • 4. Persistent Borrelia burgdorferi infection after treatment with antibiotics and anti-tumor necrosis factor-alpha.
    Stricker RB; Johnson L
    J Infect Dis; 2008 May; 197(9):1352-3. PubMed ID: 18422450
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice, after antibiotic treatment.
    Liegner KB
    J Infect Dis; 2003 May; 187(10):1676; author reply 1676. PubMed ID: 12721952
    [No Abstract]   [Full Text] [Related]  

  • 6. Resurgence of persisting non-cultivable Borrelia burgdorferi following antibiotic treatment in mice.
    Hodzic E; Imai D; Feng S; Barthold SW
    PLoS One; 2014; 9(1):e86907. PubMed ID: 24466286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment.
    Bockenstedt LK; Mao J; Hodzic E; Barthold SW; Fish D
    J Infect Dis; 2002 Nov; 186(10):1430-7. PubMed ID: 12404158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A doxycycline hyclate rodent bait formulation for prophylaxis and treatment of tick-transmitted Borrelia burgdorferi.
    Dolan MC; Zeidner NS; Gabitzsch E; Dietrich G; Borchert JN; Poché RM; Piesman J
    Am J Trop Med Hyg; 2008 May; 78(5):803-5. PubMed ID: 18458316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of Borrelia burgdorferi following antibiotic treatment in mice.
    Hodzic E; Feng S; Holden K; Freet KJ; Barthold SW
    Antimicrob Agents Chemother; 2008 May; 52(5):1728-36. PubMed ID: 18316520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decorin binding proteins of Borrelia burgdorferi promote arthritis development and joint specific post-treatment DNA persistence in mice.
    Salo J; Jaatinen A; Söderström M; Viljanen MK; Hytönen J
    PLoS One; 2015; 10(3):e0121512. PubMed ID: 25816291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy.
    Bockenstedt LK; Gonzalez DG; Haberman AM; Belperron AA
    J Clin Invest; 2012 Jul; 122(7):2652-60. PubMed ID: 22728937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Borrelia burgdorferi--a unique bacterium].
    Brorson Ø
    Tidsskr Nor Laegeforen; 2009 Oct; 129(20):2114-7. PubMed ID: 19855450
    [No Abstract]   [Full Text] [Related]  

  • 13. Generality of Post-Antimicrobial Treatment Persistence of
    Hodzic E; Imai DM; Escobar E
    Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31308087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection and musculoskeletal conditions: Lyme borreliosis.
    Schnarr S; Franz JK; Krause A; Zeidler H
    Best Pract Res Clin Rheumatol; 2006 Dec; 20(6):1099-118. PubMed ID: 17127199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriocidal activity of lizard and mouse serum for Borrelia lonestari, putative agent of a Lyme-like illness (AKA STARI or Masters disease) in Missouri.
    Grigery CN; Moyer P; Little SE; Masters EJ
    Mo Med; 2005; 102(5):442-6. PubMed ID: 16259394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ineffectiveness of tigecycline against persistent Borrelia burgdorferi.
    Barthold SW; Hodzic E; Imai DM; Feng S; Yang X; Luft BJ
    Antimicrob Agents Chemother; 2010 Feb; 54(2):643-51. PubMed ID: 19995919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of an evernimicin (SCH27899) in vitro and in an animal model of Lyme disease.
    Pavia CS; Wormser GP; Nowakowski J; Cacciapuoti A
    Antimicrob Agents Chemother; 2001 Mar; 45(3):936-7. PubMed ID: 11181384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Testing of Serial Blood Specimens from Patients with Early Lyme Disease during Treatment Reveals Changing Coinfection with Mixtures of Borrelia burgdorferi Genotypes.
    Mosel MR; Carolan HE; Rebman AW; Castro S; Massire C; Ecker DJ; Soloski MJ; Aucott JN; Eshoo MW
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31036693
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeting of vascular adhesion protein-1 by positron emission tomography visualizes sites of inflammation in Borrelia burgdorferi-infected mice.
    Siitonen R; Pietikäinen A; Liljenbäck H; Käkelä M; Söderström M; Jalkanen S; Hytönen J; Roivainen A
    Arthritis Res Ther; 2017 Nov; 19(1):254. PubMed ID: 29166944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lyme Borreliosis: Is there a preexisting (natural) variation in antimicrobial susceptibility among Borrelia burgdorferi strains?
    Hodzic E
    Bosn J Basic Med Sci; 2015 Jul; 15(3):1-13. PubMed ID: 26295288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.